Loading…
Thymoma-associated autoimmune encephalitis with positive Titin antibodies: A case report
We report a case of thymoma-associated autoimmune encephalitis with positive Titin antibodies. The patient had cognitive dysfunction, psychiatric symptoms and symptomatic epilepsy. PET-CT indicated space-occupied lesion at the thoracic entrance. The patient was diagnosed with paraneoplastic autoimmu...
Saved in:
Published in: | Journal of neuroimmunology 2021-09, Vol.358, p.577670-577670, Article 577670 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We report a case of thymoma-associated autoimmune encephalitis with positive Titin antibodies. The patient had cognitive dysfunction, psychiatric symptoms and symptomatic epilepsy. PET-CT indicated space-occupied lesion at the thoracic entrance. The patient was diagnosed with paraneoplastic autoimmune encephalitis. After immunotherapy, his condition improved and underwent thymectomy. Pathology revealed type A thymoma. The patient recurred 10 days after the operation. Thymoma is associated with AE. And Titin antibodies may be involved in the extensive immune response to antigens which the patient's thymoma ectopically expressed. This case reflects the complexity of the immune relationship among autoimmune encephalitis, Titin antibodises and thymoma. Titin antibody may have a certain guiding significance for the treatment and prognosis of autoimmune encephalitis.
[Display omitted]
•Anti-Titin may be involved in the extensive immune response to antigens which the thymoma ectopically expressed•Thymoma-associated autoimmune encephalitis with positive anti-Titin may relapse after thymectomy.•Titin may expose many different possible antigens / antibody sites for autoimmune reactions by molecular mimicry. |
---|---|
ISSN: | 0165-5728 1872-8421 |
DOI: | 10.1016/j.jneuroim.2021.577670 |